Council for Innovation Promotion

C4IP is a bipartisan coalition dedicated to promoting strong and effective IP rights that drive innovation, boost economic competitiveness, and improve lives.

[Council for Innovation Promotion @Council4IP]

📣 Council for Innovation Promotion Report Finds Congress Continues to Underperform on Innovation Policy

Today, C4IP released its third annual Congressional Innovation Scorecard, offering a comprehensive assessment of how every member of Congress engages with policies that shape America's innovation ecosystem.

Read our full statement:
https://t.co/sWOKApLrgb

[Council for Innovation Promotion @Council4IP]

📝 READ C4IP's letter to the House Judiciary IP Subcommittee regarding today's hearing on "Medicines and IP: Balancing Innovation and Access."

https://t.co/lyM4de8vzB

[Council for Innovation Promotion @Council4IP]

Watch the full hearing here:
https://t.co/6Nij4x3OmR

[Council for Innovation Promotion @Council4IP]

Today, C4IP Chief Policy Officer and Counsel Jamie Simpson testified before the House Judiciary IP Subcommittee at its hearing on "Medicines and IP: Balancing Innovation and Access."

We rounded up some key highlights from her oral testimony. Take a look ⬇️

[Council for Innovation Promotion @Council4IP]

"Drug affordability matters -- but weakening the patent system based on claims the evidence does not support is unlikely to fix it, and it risks undermining the innovation ecosystem that has delivered extraordinary advances for American patients."

[Council for Innovation Promotion @Council4IP]

As inventors refine their work, they'll often file additional patent applications to claim the full scope of their invention more accurately.

Terminal disclaimers accommodate that evolution by allowing those refinements to issue as valid claims without creating duplicative patent terms.

Check out our fact sheet for more 👇
https://t.co/n5fnhgHgu0

[Council for Innovation Promotion @Council4IP]

📷 Check out these photos of C4IP Co-Chair Andrei Iancu delivering remarks at the @AcadofInventors' 15th Annual Conference!

His comments highlighted how America became an innovation powerhouse and world's largest economy largely due to the IP rights enshrined in the Constitution.

[Council for Innovation Promotion @Council4IP]

Although strong patents play a crucial role in promoting innovation in the drug industry and beyond, lawmakers and activists cite myths about how patent rights affect competition to justify legislation that would weaken patents.

This one-pager sets the record straight ⬇️
https://t.co/z8RGRdUlh1

[Council for Innovation Promotion @Council4IP]

📣 C4IP Executive Director Frank Cullen released the following statement applauding the nomination of Peter-Anthony Pappas to @TradeGov:

"C4IP congratulates Peter-Anthony Pappas on his nomination to serve as a Member of the United States International Trade Commission..."

Read more:
https://t.co/TOxu60jAQQ

[Council for Innovation Promotion @Council4IP]

✖️ Myth: The ETHIC Act simply prevents companies from "stacking" patents in litigation.

✅ Fact: The bill would do far more than that. It would sharply restrict the ability to enforce valid patents by allowing inventors to assert only one patent from a family in court.

Learn more:
https://t.co/S43x7BZk9V

[Council for Innovation Promotion @Council4IP]

Check out this @Law360 op-ed by @oshaughnessy_b, partner at Dinsmore & Shohl, LLP:

"The SEP licensing framework has enabled decades of innovation, investment and broad interoperability. Preserving that progress requires maintaining the straightforward expectation that commerce relies upon: When parties make a deal, they must keep it."

Read more:
https://t.co/VS2XW76kg1

[Council for Innovation Promotion @Council4IP]

In the News 📰

@news6wkmg highlighted C4IP's latest statement on the NO FAKES Act:

"'The growing sophistication of AI-generated deepfakes underscores the need for robust, clear, and consistent federal safeguards,' said Frank Cullen, executive director of C4IP."

For more 👇
https://t.co/urPshuYD29

[Council for Innovation Promotion @Council4IP]

As the United States approaches its 250th anniversary, join C4IP and @IPPolicyInst for a timely discussion on "IP at America's 250th."

📅 Jun 10, 2026
⏰ 1-2:30 PM ET

For more details and to register ⬇️
https://t.co/DuxnCiZ6nJ

[Council for Innovation Promotion @Council4IP]

While some claim that companies file multiple patents for a single product to “game” the patent system, there’s nothing insidious or abnormal about this practice.

There are often many distinct and novel innovations that go into a single product. Patents can cover separate -- yet equally important -- characteristics.

Crucially, if an inventor files a patent for a variant of their product that would not qualify for its own standalone patent, the new patent is given the same expiration date as the product’s original patent. Otherwise, the patent for the new variant is denied.

Learn more: https://t.co/gszIQ6ircn

[AAM @AccessibleMeds]

Patent Thickets Block Affordable Medicines.

Brand-name drug companies use patent thickets to stack dozens of overlapping patents and delay generic competition, instead of focusing on innovating new medicines. This keeps drug prices high!

Policymakers must act NOW to rein in patent thickets and bring affordable medicines to America’s patients faster.

Learn more: https://t.co/5rjWOYKn3Y

[Council for Innovation Promotion @Council4IP]

📫 Stay in the know on all things intellectual property and innovation!

Subscribe to our monthly newsletter for expert insights, fact-checks, coalition updates, and much more 👇

https://t.co/3GUkAoeFPa

[Council for Innovation Promotion @Council4IP]

💻 Learn the truth behind common patent myths like so-called "patent evergreening,” "product hopping," and "patent thickets." Our webpage breaks down these misconceptions and sets the record straight.

By debunking these myths, we hope to foster a more honest public policy debate.

Take a look:
https://t.co/cws2BhVtW3